New Impact Factor for Cardiovascular Diagnosis and Therapy: 2.1

Published: 2024-06-21

We are pleased to announce that Cardiovascular Diagnosis and Therapy (CDT) has attained its latest impact factor update for the 2023 citation year: 2.1 (Figure 1).

Figure 1. 2023 Impact Factor of CDT.

Cardiovascular Diagnosis and Therapy (Print ISSN: 2223-3652; Online ISSN: 2223-3660; Cardiovasc Diagn Ther; CDT) is an open access, peer-reviewed, international English-language journal indexed by PubMed/PubMed Central and Science Citation Index Expanded (SCIE). The journal publishes manuscripts that describe novel findings in the diagnosis and therapy of cardiovascular diseases including contributions related to clinical cardiology, cardiothoracic surgery, public heath, nursing, sociology, human genetics, basic sciences, education, and the environment.

We strive to follow the best practices in publishing. The announcement of the journal’s latest impact factor is not only a significant achievement for the journal but also strengthens our commitment to further advance our journal. We would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, authors, reviewers and readers for their significant contributions.

We look forward to the continuous cooperation with all the individuals mentioned above and those who are interested in bringing exciting content to our readers in the coming future.

Editorial Office
Cardiovascular Diagnosis and Therapy

June 21, 2024